Understanding Your SPF Data (FDA Method) Webinar

Sunscreens are regulated by the FDA as Over the Counter (OTC) drugs. Before they enter the market, they must be shown to be both safe and effective and must comply with requirements listed in the FDA’s OTC sunscreen monograph. This webinar has been assembled as an educational session to help sunscreen suppliers, formulators, marketers, and manufacturers understand the pertinent details behind the SPF product testing.

Topics include, an overview of the FDA method, determination and validation of SPF values, product performance as it pertains to the FDA monograph, understanding the results of your SPF testing and how to interpret these results for industry compliance and label claims. After attending this webinar, participants will be in a better position to make strategic well-informed decisions based on the data they will receive from this type of testing and analysis that best fits their needs and product development goals.

Tuesday, January 30th 2024 10am-11am EST Register & 2pm-3pm EST Register

Tuesday, February 27th 2024 10am-11am EST Register & 2pm-3pm EST Register

Tuesday, March 26th 10am-11am EDT Register & 2pm-3pm EDT Register 


Chelcie Mejia
Chelcie Mejia is currently the Photobiology Manager at Eurofins CRL Cosmetics, Inc. North Carolina, USA where she is the Principal Investigator of the In-Vivo and In-Vitro SPF studies and oversees the daily clinical testing operations of R&D sun protecting products.  She has 5+ years of experience in the SPF industry.

Dominique Sawyer
Dominique Sawyer is currently the Photobiology Team Lead at Eurofins CRL Cosmetics, Inc. North Carolina, USA where he is responsible for initiating the studies, including IRB submissions and product check in. Dominique also handles the training procedures for our new staff members and test product assignment. He has been with the company for almost a year.

For all of our Sunscreen Testing Services, please Click Here.

For additional Testing Services, please Click Here.

Related Posts

Sorry, the comment form is closed at this time.